MultiPlan Corp Stock: price and insider trades · United States · SEC (Form 4)Track the MultiPlan Corp stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, MultiPlan Corp has logged 107 insider filings. The latest transaction was filed on 19 November 2024 (Acquisition). Among the most active insiders: Tabak Mark. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 November 2024
All Executives107 Thresholds0 Prospectus0 Other0
Declarations 107 total
▲ SVP, Chief Information Officer · Executives · 15 Nov 2024
40,000 shares @ US$6.2397 50.0% of flow Class A common stock SEC:0001793229-24-000151:0
Canonical exit: 13 Feb 2025 (T+90) ◆ SVP, Chief Growth Officer · Executives · 14 Oct 2024
95,328 shares 0Class A common stock, par value $0.0001 per share SEC:0001793229-24-000141:0
▲ SVP, Corp. Affairs/Strategy · Executives · 6 Aug 2024
81,165 shares @ US$0.3149 100.0% of flow Class A common stock SEC:0001793229-24-000129:0
Canonical exit: 4 Nov 2024 (T+90) ◆ EVP, CFO & Treasurer · Executives · 5 Aug 2024
3,571,428 shares 0Class A common stock SEC:0001793229-24-000124:0
◆ SVP, Corp. Affairs/Strategy · Executives · 5 Aug 2024
1,928,571 shares 0Class A common stock SEC:0001793229-24-000120:0
▲ Pres., Chief Executive Officer · Executives · 7 Aug 2024
500,000 shares @ US$0.37 3.5% of flow Class A common stock SEC:0001793229-24-000127:0
Canonical exit: 5 Nov 2024 (T+90) ▲ Director · Executives · 16 May 2024
160,000 shares @ US$0.60 28.5% of flow Class A common stock SEC:0001793229-24-000086:0
Canonical exit: 14 Aug 2024 (T+90) ◆ Director · Executives · 24 Apr 2024
172,413 shares 0Class A common stock SEC:0001793229-24-000066:0
◆ Director · Executives · 24 Apr 2024
172,413 shares 0Class A common stock SEC:0001793229-24-000068:0
◆ Director · Executives · 24 Apr 2024
172,413 shares 0Class A common stock SEC:0001793229-24-000070:0
◆ Director · Executives · 24 Apr 2024
172,413 shares 0Class A common stock SEC:0001793229-24-000065:0
◆ Director · Executives · 24 Apr 2024
172,413 shares 0Class A common stock SEC:0001793229-24-000072:0
◆ Director · Executives · 24 Apr 2024
172,413 shares 0Class A common stock SEC:0001793229-24-000064:0
◆ Director · Executives · 24 Apr 2024
172,413 shares 0Class A common stock SEC:0001793229-24-000067:0
● SVP, Chief Information Officer · Executives · 29 Mar 2024
2,510 shares @ US$0.81 0.4% of flow Class A common stock SEC:0001793229-24-000054:0
● SVP, Chief Accounting Officer · Executives · 29 Mar 2024
2,958 shares @ US$0.81 6.8% of flow Class A common stock SEC:0001793229-24-000056:0
● Executive Chair · Executives · 29 Mar 2024
20,120 shares @ US$0.81 6.5% of flow Class A common stock SEC:0001793229-24-000050:0
● EVP, General Counsel · Executives · 29 Mar 2024
2,781 shares @ US$0.81 6.3% of flow Class A common stock SEC:0001793229-24-000052:0
◆ EVP, Chief Operating Officer · Executives · 11 Mar 2024
1,041,667 shares 0Class A common stock SEC:0001793229-24-000040:0
● EVP, General Counsel · Executives · 1 Mar 2024
8,436 shares @ US$1.11 26.1% of flow Class A common stock SEC:0001793229-24-000030:0
● SVP, Chief People Officer · Executives · 1 Mar 2024
46,500 shares @ US$1.11 100.0% of flow Class A common stock SEC:0001793229-24-000022:0
● SVP, Chief Accounting Officer · Executives · 1 Mar 2024
7,362 shares @ US$1.11 23.2% of flow Class A common stock SEC:0001793229-24-000024:0
● EVP & Chief Financial Officer · Executives · 1 Mar 2024
226,997 shares @ US$1.11 9.2% of flow Class A common stock SEC:0001793229-24-000028:0
● Executive Chair · Executives · 1 Mar 2024
60,966 shares @ US$1.11 26.9% of flow Class A common stock SEC:0001793229-24-000016:0
● SVP, Chief Information Officer · Executives · 1 Mar 2024
7,545 shares @ US$1.11 1.6% of flow Class A common stock SEC:0001793229-24-000026:0
25 of 107 declarations
Load more (82 remaining) 关于 MultiPlan Corp MultiPlan Corp. 是一家在美国纽约证券交易所上市的公司,股票代码为 MPLN,于 2025 年 2 月更名为 Claritev Corporation;对于追踪 MPLN 历史的投资者来说,这是现在以新市场身份运营的同一业务血统。该公司总部位于美国,主要执行办公室位于纽约市第五大道 115 号,纽约,邮编 10003。其运营根源可追溯到 1980 年,当时 MultiPlan 成立为医疗保健成本管理平台。([sec.gov](https://www.sec.gov/Archives/edgar/data/1793229/000179322922000037/a2022proxystatement14afili.htm?utm_source=openai))
在运营上,该集团被定位为一家技术和数据驱动的医疗保健解决方案提供商,专注于为美国医疗保健系统提供支付完整性、基于网络的成本管理、分析和决策支持工具。MultiPlan 表示,它服务于 700 多家医疗保健支付方、超过 100,000 家雇主、60 million 消费者和 1.4 million 签约提供商,突显了其在报销链中的广泛覆盖。这种规模很重要,因为该公司处于一个庞大、经常性且高度受监管的工作流程中:识别医疗节省、提高支付准确性以及帮助减少余额账单和其他可避免的成本。([sec.gov](https://www.sec.gov/Archives/edgar/data/1793229/000179322924000136/exhibit991pressreleasedate.htm))
从竞争角度来看,MultiPlan 长期以来通过专有数据、网络资产和分析的结合而非纯粹的索赔处理模式来区分自己。在其 2016 年的收购公告中,该公司将自己描述为美国最大的提供减少医疗成本的交易型解决方案的提供商,以及一家技术驱动、数据驱动的成本管理业务。其客户群历来包括保险公司、健康计划、第三方管理机构、自保雇主、HMO 和其他支付医疗费用的实体,这使其在美国医疗保健领域拥有多元化的终端市场敞口。([multiplan.com](https://www.multiplan.com/webcenter/wccproxy/d?dDocName=hellman_friedman_acquisition))
近期公司发展对投资者尤为重要。2024 年 9 月 20 日,MultiPlan 完成了 1 股拆 40 股的反向股票分割,主要目的是提高每股交易价格以满足纽约证券交易所的上市要求。随后,2025 年 2 月 17 日,公司将名称从 MultiPlan Corporation 更改为 Claritev Corporation,并宣布其普通股预计将于 2025 年 2 月 28 日起以新股票代码 CTEV 在纽约证券交易所交易。美国证券交易委员会的文件还提到了 2024 年末和 2025 年初的债务置换和再融资活动,这表明正在进行资产负债表重组。对于股票投资者而言,关键在于 MPLN 的运营故事是一家美国医疗保健技术和数据业务,但其公开市场形象主要受到上市合规行动和资本结构调整的重大影响。([sec.gov](https://www.sec.gov/Archives/edgar/data/1793229/000179322924000136/exhibit991pressreleasedate.htm?utm_source=openai))